This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Diamedica USA Inc.. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: Rick Pauls: Innovator in Ulinastatin Polypeptides
Introduction
Rick Pauls is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of biotechnology, particularly through his work on ulinastatin polypeptides. His innovative approach has led to advancements in the treatment of various diseases.
Latest Patents
Rick Pauls holds a patent for ulinastatin polypeptides. This patent includes ulinastatin glycoforms, ulinastatin fusion polypeptides, and related compositions, mixtures, and methods of use. It also encompasses methods for recombinantly producing ulinastatin polypeptides and their application in treating diseases.
Career Highlights
Throughout his career, Rick has demonstrated a commitment to research and development in the biotechnology sector. His work has not only contributed to scientific knowledge but has also paved the way for new therapeutic options.
Collaborations
Rick has collaborated with notable colleagues, including Todd Verdoorn and Karl Frank Johnson. These partnerships have enhanced the scope and impact of his research.
Conclusion
Rick Pauls is a distinguished inventor whose work on ulinastatin polypeptides has the potential to transform treatment methodologies in medicine. His contributions reflect a dedication to innovation and the advancement of healthcare solutions.